Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ATR | Q13535 | 14/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.37 |
| ▸ | PRKDC | P78527 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12077869 | 0.94 | MAPK1 (0.46) | MAPK1ATRKCNH2GSK3BMAPKAPK2 | |
| SCHEMBL12496051 | 0.93 | MAPK1 (0.42) | MAPK1ATRKCNH2GSK3BMAPKAPK2 | |
| SCHEMBL12078097 | 0.93 | ATR (0.40) | MAPK1ATRKCNH2PRKDCATM | |
| SCHEMBL12495170 | 0.92 | MAPK1 (0.45) | MAPK1ATRKCNH2GSK3BPRKDC | |
| SCHEMBL12495193 | 0.89 | MAPK1 (0.41) | MAPK1ATRKCNH2GSK3BPRKDC | |
| SCHEMBL18936992 | 0.89 | MAPK1 (0.43) | MAPK1ATRKCNH2MAPKAPK2PRKDC | |
| SCHEMBL12495789 | 0.87 | KCNH2 (0.39) | MAPK1ATRKCNH2PRKDCATM | |
| SCHEMBL18936949 | 0.87 | MAPK1 (0.44) | MAPK1ATRKCNH2GSK3BMAPKAPK2 | |
| SCHEMBL12495224 | 0.87 | MAPK1 (0.44) | MAPK1ATRKCNH2GSK3BMAPKAPK2 | |
| SCHEMBL18964377 | 0.86 | MAPK1 (0.43) | MAPK1ATRKCNH2GSK3BMAPKAPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2681206-B1 | MST1 KINASE INHIBITORS AND METHODS OF THEIR USE | LEXICON PHARMACEUTICALS INC (US) | 2017-06-14 | — | — | EP | disclosed |